The shares of Depomed, Inc. (NASDAQ:DEPO) started off the last trading session with the price of $7.04 while closing the day with the price of $6.81. The shares of Depomed, Inc. (NASDAQ:DEPO) Fell -2.99% with the Loss of -0.23 points.
The shares of Depomed, Inc. (NASDAQ:DEPO) traded with the day volume of 1.57 Million shares whereas its average trading volume is 1.17 Million.
While analyzing the past performance of the stock we can see that the shares of Depomed, Inc. (NASDAQ:DEPO) Loss -2.01% in the last week while Falling -2.3% in the last month. Past quarter performance shows the red light with -19.41%. The semi-annual and annual performance shows 6.07% and -57.73% respectively.
Some critical values of the shares of Depomed, Inc. (NASDAQ:DEPO) to be discussed here are: the beta which shows the value at 1.18 while Average True Range of Depomed, Inc. (NASDAQ:DEPO) demonstrate the value at 0.38. The weekly and monthly volatility of the shares of Depomed, Inc. (NASDAQ:DEPO) are indicated at 4.32% and 5.55%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 42.11.
While studying the financial position of the shares of Depomed, Inc. (NASDAQ:DEPO), we can see that the Market capitalization of the company is at 442.38 Million. The shares outstanding for the company is 64.96 Million and the shares float stands at 62.19 Million. The income of the company stand at -77000000 while the sales stand at 380.7 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -1.23, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 1.16, the Return on Asset ROA stood at -0.094 and the Return on Equity ROE depicted at -0.506 while Return on Investment ROI is at -0.005.
Alder Biopharmaceuticals Inc. (NASDAQ:ALDR)
Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) started its previous trading session at $14.1 and closed at $14.15 showing a Rise of 0.71 Percent.
The Company traded with an average Volume of 1.61 Million whereas, its Day Volume stood at 1.57 Million.
Looking at the performance of the stock, Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) Loss -6.91% in the last week in its shares price and -1.39% in the last month. Quarterly performance shows a green of 28.05 Percent while Semi-Annual and Annual performances shows a 42.21 and -39.53 percent respectively.
Beta for Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) stands at 2.51 while the ATR (average true range) is at 0.77. The Stock’s Weekly and Monthly Volatility is 5.14% and 5.14% respectively showing a RSI value of 43.64.
While studying the financial position of the shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), we can see that the Market capitalization of the company is at 953.14 Million. The shares outstanding for the company is 67.36 Million and the shares float stands at 66.94 Million.
The Company generated an income of -288900000 and the sales of 1.6 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-5.2 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 595.71 respectively.
The Return on Assets stands at -0.931, ROE shows a value of -1.038 and ROI for Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) is -1.042 as of Trailing Twelve Months period.
